These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 36837931)

  • 1. Concentrations of Plasma Amino Acids and Neurotransmitters in Participants with Functional Gut Disorders and Healthy Controls.
    James SC; Fraser K; Cooney J; Günther CS; Young W; Gearry RB; Heenan PE; Trower T; Keenan JI; Talley NJ; McNabb WC; Roy NC
    Metabolites; 2023 Feb; 13(2):. PubMed ID: 36837931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of Fecal Bile Acids in Participants with Functional Gut Disorders and Healthy Controls.
    James SC; Fraser K; Young W; Heenan PE; Gearry RB; Keenan JI; Talley NJ; Joyce SA; McNabb WC; Roy NC
    Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota profiles and the role of anti-CdtB and anti-vinculin antibodies in patients with functional gastrointestinal disorders (FGID).
    Vasapolli R; Schulz C; Schweden M; Casèn C; Kirubakaran GT; Kirste KH; Macke L; Link A; Schütte K; Malfertheiner P
    Eur J Clin Invest; 2021 Dec; 51(12):e13666. PubMed ID: 34390492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small Intestinal Bacterial Overgrowth In Various Functional Gastrointestinal Disorders: A Case-Control Study.
    Chuah KH; Wong MS; Tan PO; Lim SZ; Beh KH; Chong SCS; Zulkifli KK; Thalha AM; Mahadeva S; Lee YY
    Dig Dis Sci; 2022 Aug; 67(8):3881-3889. PubMed ID: 34417923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results From a Preliminary Retrospective Study.
    Kumbhare SV; Francis-Lyon PA; Kachru D; Uday T; Irudayanathan C; Muthukumar KM; Ricchetti RR; Singh-Rambiritch S; Ugalde J; Dulai PS; Almonacid DE; Sinha R
    Front Microbiol; 2022; 13():826916. PubMed ID: 35391720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, overlap, and risk factors for Rome IV functional gastrointestinal disorders among college students in northern India.
    Goyal O; Nohria S; Dhaliwal AS; Goyal P; Soni RK; Chhina RS; Sood A
    Indian J Gastroenterol; 2021 Apr; 40(2):144-153. PubMed ID: 33226570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epidemiology and quality of life of functional gastrointestinal disorders according to Rome III vs Rome IV criteria: A cross-sectional study in primary care.
    Chuah KH; Beh KH; Mahamad Rappek NA; Mahadeva S
    J Dig Dis; 2021 Mar; 22(3):159-166. PubMed ID: 33595169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of serum gastric peptide ghrelin hormone level in irritable bowel syndrome at Zagazig University Hospitals.
    Monem SMA; Elbadrawy EG; Shalaby SM; Hendawy DM; Hassan SM; Almonem NA
    J Med Life; 2022 Dec; 15(12):1525-1531. PubMed ID: 36762339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilising lipid and, arginine and proline metabolism in blood plasma to differentiate the biochemical expression in functional dyspepsia (FD) and irritable bowel syndrome (IBS).
    Karpe AV; Liu JW; Shah A; Koloski N; Holtmann G; Beale DJ
    Metabolomics; 2022 Jun; 18(6):38. PubMed ID: 35687195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C; Monaghan PJ; Morris J; Issa B; Whorwell PJ; Keevil B; Houghton LA
    Gastroenterology; 2013 Oct; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of patients with overlap functional gastrointestinal disorders.
    Bouchoucha M; Deutsch D; Uong P; Mary F; Sabate JM; Benamouzig R
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2171-2179. PubMed ID: 33555092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Shiha MG; Asghar Z; Thoufeeq M; Kurien M; Ball AJ; Rej A; Tai FWD; Afify S; Aziz I
    Neurogastroenterol Motil; 2021 Oct; 33(10):e14121. PubMed ID: 33719130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there an association between GNbeta3-C825T genotype and lower functional gastrointestinal disorders?
    Andresen V; Camilleri M; Kim HJ; Stephens DA; Carlson PJ; Talley NJ; Saito YA; Urrutia R; Zinsmeister AR
    Gastroenterology; 2006 Jun; 130(7):1985-94. PubMed ID: 16762621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolomics analysis revealed metabolic changes in patients with diarrhea-predominant irritable bowel syndrome and metabolic responses to a synbiotic yogurt intervention.
    Noorbakhsh H; Yavarmanesh M; Mortazavi SA; Adibi P; Moazzami AA
    Eur J Nutr; 2019 Dec; 58(8):3109-3119. PubMed ID: 30392136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Tong Xie Yao Fang on endogenous metabolites in urine of irritable bowel syndrome model rats.
    Zhao XY; Wang JW; Yin Y; Li K; Zhang M; Yan FP
    World J Gastroenterol; 2019 Sep; 25(34):5134-5151. PubMed ID: 31558862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome.
    Su Q; Tun HM; Liu Q; Yeoh YK; Mak JWY; Chan FK; Ng SC
    Gut Microbes; 2023; 15(1):2157697. PubMed ID: 36573834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased prevalence of functional gastrointestinal disorders in panic disorder: clinical and theoretical implications.
    Lydiard RB
    CNS Spectr; 2005 Nov; 10(11):899-908. PubMed ID: 16273019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.